Russian president Vladimir PutinVladimir Vladimirovich Putin Trump will take part in a virtual G20 summit amid a wave of coronavirus New marshmallow media in the Biden era How to fight Putin’s financial aggression on Saturday told the leaders of the G20 summit this weekend in Saudi Arabia that Russia was ready to spread its Sputnik V coronavirus vaccine to other countries.
According to Reuters, Russia is also preparing its second and third vaccines, telling other world leaders that creating a portfolio of vaccines is “our common goal.”
The message to the G20, which consists of 19 countries, including the United States, France, Germany, the United Kingdom and Japan, as well as the European Union, comes as some raise doubts about the safety and efficacy of the Russian vaccine.
Earlier this month, Russia announced that the data on the interim proceedings showed that Sputnik V is 92 percent effective in protecting people from the virus. Although the experts noted that this was encouraging, they also indicated that the data were taken from a small number of 20 volunteers who agreed with COVID-19.
The size of the study was significantly less than the 94 cases of coronavirus concluded by study participants from the drug manufacturer Pfizer and the German manufacturing company BioNTech.
Some have suggested that Russia was forced to announce the effectiveness of its vaccine, as it came two days after Pfizer said its candidate was over 90% effective.
Since then, final data reveal that the Pfizer vaccine is available 95 percent efficiency “Against COVID-19, starting 28 days after the first dose.”
Pfizer and BioNTech announced on Friday that they are doing so has applied for an emergency permit from the Food and Drug Administration.
In addition to the United States, the companies have already started applying in Europe and the UK and intend to submit more “in the coming days”. The companies said they would be ready to distribute the vaccine immediately after authorization.
However, experts predict that after federal approval, the doses are likely to be available only to frontline health workers and other higher-risk groups by the end of the year, with enough doses to be widely distributed to the general public by spring or summer 2021.
According to coronavirus data collected by Johns Hopkins University, Russia currently ranks fifth in the world in the number of total infections with COVID-19, with over 2 million registered.
The United States currently has the highest number of reported cases in any country in the world, with 12 million infections, followed by India, Brazil and France.